No connection

Search Results

BKE

NEUTRAL
$50.28 Live
The Buckle, Inc. · NYSE
Target $55.0 (+9.4%)
$33.12 52W Range $61.69

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Mar 14, 2026
Market cap
$2.57B
P/E
12.29
ROE
41.3%
Profit margin
16.1%
Debt/Equity
0.73
Dividend yield
2.78%

AI Analysis

AI-powered fundamental assessment

Confidence
78%
BKE's Piotroski F-Score of 4/9 indicates weak financial health, signaling potential distress in operational efficiency and capital structure. The absence of an Altman Z-Score raises concern about bankruptcy risk, though the company maintains strong profitability metrics including a 41.26% ROE and 16.13% profit margin. Trading at $50.28, the stock is below its intrinsic value of $84.46 and Graham Number of $30.6, suggesting undervaluation on a defensive basis, but the lack of analyst coverage and neutral insider activity limit conviction. The 52-week range ($33.12–$61.69) and recent 6-month decline highlight volatility, while earnings growth remains solid but inconsistent.

Key Strengths

Strong profitability with 41.26% ROE and 16.13% profit margin
High gross margin of 58.95% indicates pricing power and cost control
Intrinsic value ($84.46) significantly exceeds current price ($50.28), suggesting undervaluation
Consistent revenue and earnings growth (9.3% and 9.1% YoY respectively)
Low payout ratio (34.23%) supports sustainable dividend and reinvestment capacity

Key Risks

Piotroski F-Score of 4/9 indicates weak financial health and operational instability
No Altman Z-Score available, raising unquantified bankruptcy risk
Neutral insider sentiment with zero buy/sell activity in last 6 months
Technical trend is bearish (0/100), indicating downward momentum
Lack of analyst coverage (only 1 analyst) limits market consensus and forward guidance
AI Fair Value Estimate
Based on comprehensive analysis
$84.46
+68.0% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
65
Strong
Value
85
Future
68
Past
72
Health
45
Dividend
55
AI Verdict
neutral
Key drivers: Strong profitability and intrinsic value, Weak Piotroski F-Score and missing Altman Z-Score, Neutral technicals and insider activity, Solid growth but inconsistent earnings surprises, Undervaluation on Graham and intrinsic basis
Confidence
78%
Value
85/100

Ref P/E, PEG, Graham Number

Positives
  • Current price ($50.28) is below Graham Number ($30.6) and intrinsic value ($84.46)
  • P/E of 12.29 is significantly below sector average (42.79)
  • Price/Sales of 2.01 is reasonable for a retail company with strong margins
Watchpoints
  • PEG ratio unavailable, limiting growth-adjusted valuation analysis
  • Price/Book of 4.94 suggests premium valuation relative to book value
Future
68/100

Ref Growth rates

Positives
  • 9.3% YoY revenue growth and 9.1% earnings growth indicate sustained expansion
  • Recent Q/Q EPS growth of 65.6% signals strong momentum
  • Positive earnings surprises in 3 of last 4 quarters (avg +4.33%)
Watchpoints
  • No forward PEG ratio available, limiting growth valuation clarity
  • Earnings growth has decelerated from prior years (e.g., 2021–2022 highs)
Past
72/100

Ref Historical trends

Positives
  • 25-quarter earnings track record with 19 positive surprises
  • Historical EPS growth of +3.9% YoY and +65.6% Q/Q in most recent quarter
  • Consistent beat rate of 76% over 25 quarters
Watchpoints
  • Significant negative surprises in 2020–2024 (e.g., -70.3% in 2020 Q2)
  • Recent quarters show mixed performance (e.g., -6.8% surprise in 2024 Q1)
Health
45/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Debt/Equity of 0.73 is moderate and below sector average (1.65)
  • Current ratio of 2.21 and quick ratio of 1.43 indicate solid liquidity
Watchpoints
  • Piotroski F-Score of 4/9 is below threshold for financial stability
  • No Altman Z-Score available, which is a critical red flag for default risk
  • Missing cash and debt data limits full health assessment
Dividend
55/100

Ref Yield, Payout

Positives
  • Dividend yield of 2.78% is attractive for a cyclical retail stock
  • Payout ratio of 34.23% is sustainable and well below 100%
Watchpoints
  • No 5-year average yield or dividend growth history available
  • Dividend strength score of 50/100 indicates moderate reliability

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$50.28
Analyst Target
$55.0
Upside/Downside
+9.4%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BKE and closest competitors.

Updated 2026-03-13
BKE
The Buckle, Inc.
Primary
5Y
+98.1%
3Y
+80.9%
1Y
+55.9%
6M
-9.4%
1M
-3.6%
1W
-1.2%
HOG
Harley-Davidson, Inc.
Peer
5Y
-49.0%
3Y
-33.4%
1Y
+1.1%
6M
-13.3%
1M
+18.0%
1W
-4.1%
AND
Andersen Group Inc.
Peer
5Y
-1.8%
3Y
-1.8%
1Y
-1.8%
6M
-1.8%
1M
-9.4%
1W
-1.2%
AMB
Ardagh Metal Packaging S.A.
Peer
5Y
-39.2%
3Y
+7.4%
1Y
+73.1%
6M
+20.4%
1M
+8.6%
1W
+0.9%
BRS
Brightstar Lottery PLC
Peer
5Y
+15.2%
3Y
-25.8%
1Y
+3.8%
6M
-0.6%
1M
-10.2%
1W
-1.2%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
12.29
Forward P/E
11.06
PEG Ratio
N/A
P/B Ratio
4.94
P/S Ratio
2.01
EV/Revenue
2.0
EV/EBITDA
9.09
Market Cap
$2.57B

Profitability

Profit margins and return metrics

Profit Margin 16.13%
Operating Margin 18.99%
Gross Margin 58.95%
ROE 41.26%
ROA 15.64%

Growth

Revenue and earnings growth rates

Revenue Growth +9.3%
Earnings Growth +9.1%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth +10.3%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.73
Moderate
Current Ratio
2.21
Strong
Quick Ratio
1.43
Good
Cash/Share
$6.78

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.3B
Gross Margin
48.0%
Op. Margin
19.0%
Net Margin
15.2%
Total Assets
$1.1B
Liabilities
$0.6B
Equity
$0.5B
Debt/Equity
1.11x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$0.0B
FCF Yield
78%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-22
$N/A
2026-03-13
$1.59
+5.5% surprise
2025-11-21
$0.96
+0.9% surprise
2025-08-22
$0.89
+6.6% surprise

Consumer Cyclical Sector Comparison

Comparing BKE against 386 companies in the Consumer Cyclical sector (23 bullish, 133 neutral, 230 bearish)
P/E Ratio
12.29
This Stock
vs
33.98
Sector Avg
-63.8% (Discount)
Return on Equity (ROE)
41.26%
This Stock
vs
-43.92%
Sector Avg
-193.9% (Below Avg)
Profit Margin
16.13%
This Stock
vs
-5.4%
Sector Avg
-398.9% (Weaker)
Debt to Equity
0.73
This Stock
vs
1.51
Sector Avg
-51.5% (Less Debt)
Revenue Growth
9.3%
This Stock
vs
28.42%
Sector Avg
-67.3% (Slower)
Current Ratio
2.21
This Stock
vs
2.46
Sector Avg
-10.2% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

BOUNDS HANK M.
Director
Stock Award
2026-01-30
3,000 shares
FRITZ JENSCHKE BRADY M
General Counsel
Stock Award
2026-01-30
13,000 shares
KLEIN ANGIE J.
Director
Stock Award
2026-01-30
3,000 shares
JOSHI SHRUTI S
Director
Stock Award
2026-01-30
3,000 shares
FAIRFIELD BILL L
Director
Stock Award
2026-01-30
3,000 shares
NELSON DENNIS H
Chief Executive Officer
Stock Award
2026-01-30
120,000 shares
PEETZ JOHN P III
Director
Stock Award
2026-01-30
3,000 shares
HEACOCK THOMAS B.
Chief Financial Officer
Stock Award
2026-01-30
18,400 shares
RHOADS KAREN B
Director
Stock Award
2026-01-30
3,000 shares
SHADA JAMES E
Director
Stock Award
2026-01-30
3,000 shares
MILKIE BRETT P.
Officer
Stock Award
2026-01-30
18,400 shares
HUSS MICHAEL E
Director
Stock Award
2026-01-30
3,000 shares
HOBERMAN BRUCE L
Director
Stock Award
2026-01-30
3,000 shares
RHOADS KAREN B
Director
Gift
2025-12-05
1,000 shares
NELSON DENNIS H
Chief Executive Officer
Gift
2025-11-24
1,500 shares
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
NONE
1 analysts
UBS
2025-11-10
Maintains
Neutral Neutral

Past News Coverage

Recent headlines mentioning BKE from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile